Indiana Attorney Todd Rokita filed a lawsuit this week against pharmaceutical giants Mylan and Pfizer, alleging they conspired to increase prices of a potentially life-saving injectable drug by 600%.
(CNN) — The US Food and Drug Administration approved the first nasal spray epinephrine drug for severe allergic reactions known as anaphylaxis, providing a needle-free alternative to EpiPens and ...
The U.S. Food and Drug Administration has approved ARS Pharmaceuticals' nasal spray as the first needle-free emergency treatment for potentially fatal allergic reactions. REUTERS The U.S. Food and ...
Democratic lawmakers who signed a letter to Mylan this week say that the practice of offering coupons masks the high drug prices that are paid by commercial health plans. The practice is not allowed ...
(CNN) — The US Food and Drug Administration approved the first nasal spray epinephrine drug for severe allergic reactions known as anaphylaxis, providing a needle-free alternative to EpiPens and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results